In the News

June 28, 2024 Press Release WASHINGTON, D.C. — This week, U.S. Rep. Mike Kelly (R-PA), a member of the Ways & Means Subcommittee on Health, introduced the Safer Compounding in Hospitals Act, legislation which would establish a budget-neutral program within Medicare to incentivize the preparation and compounding of intravenous (IV) drugs for Medicare beneficiaries in the inpatient hospital setting. […]

The compounding of sterile medications for parenteral administration to patients is not a new process. Its history has involved numerous important transitions, many of which have been, unfortunately, sparked by errors and harm to patients. Most of the last century has been focused on the sterility and stability of these products, which ultimately led to […]

Although the COVID-19 pandemic continues to strain budgets and resources, U.S. hospital pharmacies have made progress in adopting IV workflow management systems (IV-WMS)…

Patient safety advocate Mark Neuenschwander is now working to make hospital intravenous therapy as safe as humanly – and robotically – possible.

From Pharmacy Technology Report, March 12, 2020 In December 2014, a 65-year-old woman was at home in Bend, Ore., recovering from brain surgery she had recently undergone in Seattle. After experiencing bouts of anxiety, she went to the ER at a local hospital, where the doctor ordered IV administration of fosphenytoin, a low-risk antiseizure medication […]

That top level of quality is critical, especially in IV compounding, added Mark Neuenschwander, the founding director of THRIV, an organization advocating for accuracy in IV medication preparation.